ストックスクリーナーアプリを入手
98.61
2.93%
2.805
プレマーケット:
94.21
-4.395
-4.46%
Insmed Inc (INSM) 最新ニュース
Should Insmed’s (INSM) NASDAQ-100 Exit and TPIP Focus Require Action From Investors? - Yahoo Finance
Form 144 INSMED INC For: 22 June By Investing.com - Investing.com Canada
Michael Smith files Form 144 listing multiple INSM share sales (INSM) - Stock Titan
INSM Maintained by Evercore ISI Group -- Price Target Lowered to $160 - GuruFocus
Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise? - Yahoo Finance
Insmed’s New Lung Disease Study Data A Win For Company, Says Analyst - Stocktwits
INSM, FSLR, APTV: Dreaded Death Cross Has Formed On These Stocks — What It Means For Investors - Stocktwits
INSM Stock Dips In Extended Trading After Experimental Skin Disease Drug Fails In Study - Stocktwits
What's Driving Insmed's Recent Volatility - Kavout
3 US Pharmaceutical Stocks With Cash Flow And Pricing Risk - Sahm
Insmed Stockanalyst coverage and sector comparison at week’s end - AD HOC NEWS
Insmed Inc (MIL:1INSM) Stock Price, Trades & News - GuruFocus
InvestingPro’s Fair Value spotted Insmed’s 44% drop before it happened By Investing.com - Investing.com
Insmed Incorporated(NasdaqGS: INSM) dropped from NASDAQ-100 Index - marketscreener.com
Insmed slips as investors weigh recent analyst caution and launch expectations - Quiver Quantitative
Top Insmed (INSM) Competitors 2026 - MarketBeat
Insmed Inc (INSM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Insmed Inc (INSM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Insmed Inc (INSM) Institutional Confidence - TradingKey
Insmed Inc (INSM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Insmed Inc (INSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Insmed Inc (INSM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Insmed Inc (INSM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Insmed Inc (INSM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Insmed Inc (INSM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TD Cowen Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $243 - Moomoo
Mizuho cuts Insmed stock price target on volatility concerns - Investing.com UK
Mizuho cuts Insmed stock price target on volatility concerns By Investing.com - Investing.com Nigeria
Exome Asset Management LLC's Insmed Inc(INSM) Holding History - GuruFocus
Insmed (INSM) Sees Price Target Reduction Amid Market Sentiment Shift - GuruFocus
Monashee Investment Management LLC Acquires Shares of 50,000 Insmed, Inc. $INSM - MarketBeat
A Blueprint For Addressing Underserved Patient Populations - Clinical Leader
Nasdaq-100 Index® June 2026 Quarterly Changes - GlobeNewswire Inc.
BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $214 - Moomoo
Insmed stock hits 52-week low at 90.85 USD By Investing.com - Investing.com Nigeria
Daily Brief Health Care: Laurus Labs, Ascendis Pharma, GSK , Incyte Corp, Insmed Inc, Johnson & Johnson, Kardigan, LogicMark, Parabilis Medicines, Solventum and more - Smartkarma
Insmed slides 7.9% as risk-off tape collides with pipeline-focused positioning ahead of TPIP data - Quiver Quantitative
[Form 4] INSMED Inc Insider Trading Activity - Stock Titan
Insmed stock hits 52-week low at 90.85 USD - Investing.com
Stock Traders Purchase High Volume of Call Options on Insmed (NASDAQ:INSM) - MarketBeat
Cantor Fitzgerald reiterates Insmed stock rating on TPIP data outlook - Investing.com UK
Cantor Fitzgerald reiterates Insmed stock rating on TPIP data outlook By Investing.com - Investing.com Australia
GW&K Investment Management LLC Reduces Position in Insmed, Inc. $INSM - MarketBeat
Axiom Investors LLC DE Has $44.53 Million Position in Insmed, Inc. $INSM - MarketBeat
Insmed Inc stock (US4576693075): pipeline update and growth story in rare diseases - AD HOC NEWS
INSM: Brensocatib’s stellar launch and expanding pipeline set the stage for sustained growth - TradingView
Insmed Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
INSM Maintained by JP Morgan -- Price Target Lowered to $179 - GuruFocus
Insmed (INSM) Remains a Strong Buy Despite Recent Stock Decline - GuruFocus
William Lewis files Form 144 — INSM insider sale notice (INSM) - Stock Titan
Insmed Is Maintained at Overweight by JP Morgan - Moomoo
JPMorgan Chase & Co. Cuts Insmed (NASDAQ:INSM) Price Target to $179.00 - MarketBeat
Is Insmed (INSM) The Best Healthcare Stock to Buy Now? - Yahoo Finance
0.57%
1.15%
大文字化:
|
ボリューム (24 時間):